News & Updates

The current diagnostic criteria being used to predict gestational diabetes mellitus (GDM) is not fully reliable, but adding oral glucose tolerance test (OGTT) to the model may improve early prediction of GDM, according to a study.

Treatment with fezolinetant 30 and 45 mg daily provides relief from moderate-to-severe vasomotor symptoms (VSM) associated with menopause, suggests a study.

A retrospective study combining ex vivo and in vitro assays showed an independent association between COVID-19 and the onset of hyperglycaemia.

Individuals with metabolic syndrome (MetS) have a heightened risk of incident lung cancer, with the risk increase especially pronounced in those with a higher number of metabolic abnormalities and in women, according to a study.

A study links long-term intake of artificial sweeteners to fat accumulation, increasing the risk of obesity regardless of diet quality or caloric intake.

Children and teens who watch a lot of television often grow to be adults with metabolic syndrome, obesity, or poor fitness, according to a study.

Treatment of gestational diabetes before 20 weeks’ gestation appears to lead to a modestly lower incidence of a composite of adverse neonatal outcomes as compared with no-immediate treatment, with no substantial differences noted for pregnancy-related hypertension or neonatal lean body mass, as reported in a study.

Treatment with the glucagon-like peptide-1 receptor agonist (GLP-1 RA) albiglutide results in fewer cardiovascular events, irrespective of sodium-glucose cotransporter-2 (SGLT2) inhibitor use, among patients with type 2 diabetes (T2D) and cardiovascular disease, according to the post hoc analysis of Harmony Outcomes*.